Patents by Inventor Nicholas Michael SNEAD

Nicholas Michael SNEAD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATING HYPERTRIGLYCERIDEMIA
    Publication number: 20230212578
    Abstract: The present invention provides compositions comprising therapeutic nucleic acids such as siRNA that target ApoC3 and ANGPTL3 expression, lipid particles comprising one or more (e.g., a combination) of the therapeutic nucleic acids, and methods of delivering and/or administering the lipid particles (e.g., for treating hypertriglyceridemia in humans).
    Type: Application
    Filed: November 30, 2022
    Publication date: July 6, 2023
    Applicant: ARBUTUS BIOPHARMA CORPORATION
    Inventors: Ting CHIU, Narayanan HARIHARAN, Amy C. H. LEE, Christopher Justin PASETKA, Janet Ruth PHELPS, Nicholas Michael SNEAD, Andrew Anthony WIECZOREK
  • TARGETED COMPOSITIONS
    Publication number: 20230110295
    Abstract: The invention provides certain nucleic acids (e.g., double stranded siRNA molecules), as well as conjugates that comprise a targeting moiety, a double stranded siRNA, and optional linking groups. Certain embodiments also provide synthetic methods useful for preparing the conjugates. The conjugates are useful to target therapeutic double stranded siRNA to the liver and to treat liver diseases including hepatitis (e.g. hepatitis B and hepatitis D).
    Type: Application
    Filed: June 30, 2022
    Publication date: April 13, 2023
    Applicant: ARBUTUS BIOPHARMA CORPORATION
    Inventors: James HEYES, Richard J. HOLLAND, Adam JUDGE, Amy C. H. LEE, Alan D. MARTIN, Nicholas Michael SNEAD, Emily P. THI, Mark WOOD, Xin YE
  • Targeted compositions
    Patent number: 11427823
    Abstract: The invention provides certain nucleic acids (e.g., double stranded siRNA molecules), as well as conjugates that comprise a targeting moiety, a double stranded siRNA, and optional linking groups. Certain embodiments also provide synthetic methods useful for preparing the conjugates. The conjugates are useful to target therapeutic double stranded siRNA to the liver and to treat liver diseases including hepatitis (e.g. hepatitis B and hepatitis D).
    Type: Grant
    Filed: April 10, 2018
    Date of Patent: August 30, 2022
    Assignee: ARBUTUS BIOPHARMA CORPORATION
    Inventors: James Heyes, Richard J. Holland, Adam Judge, Amy C. H. Lee, Alan D. Martin, Nicholas Michael Snead, Emily P. Thi, Mark Wood, Xin Ye
  • COMPOSITIONS AND METHODS FOR TREATING HYPERTRIGLYCERIDEMIA
    Publication number: 20210047640
    Abstract: The present invention provides compositions comprising therapeutic nucleic acids such as siRNA that target ApoC3 and ANGPTL3 expression, lipid particles comprising one or more (e.g., a combination) of the therapeutic nucleic acids, and methods of delivering and/or administering the lipid particles (e.g., for treating hypertriglyceridemia in humans).
    Type: Application
    Filed: April 16, 2020
    Publication date: February 18, 2021
    Applicant: ARBUTUS BIOPHARMA CORPORATION
    Inventors: Ting CHIU, Narayanan HARIHARAN, Amy C. H. LEE, Christopher Justin PASETKA, Janet Ruth PHELPS, Nicholas Michael SNEAD, Andrew Anthony WIECZOREK
  • TARGETED COMPOSITIONS
    Publication number: 20200407724
    Abstract: The invention provides certain nucleic acids (e.g., double stranded siRNA molecules), as well as conjugates that comprise a targeting moiety, a double stranded siRNA, and optional linking groups. Certain embodiments also provide synthetic methods useful for preparing the conjugates. The conjugates are useful to target therapeutic double stranded siRNA to the liver and to treat liver diseases including hepatitis (e.g. hepatitis B and hepatitis D).
    Type: Application
    Filed: April 10, 2018
    Publication date: December 31, 2020
    Applicant: ARBUTUS BIOPHARMA CORPORATION
    Inventors: James HEYES, Richard J. HOLLAND, Adam JUDGE, Amy C. H. LEE, Alan D. MARTIN, Nicholas Michael SNEAD, Emily P. THI, Mark WOOD, Xin YE
  • COMPOSITIONS AND METHODS FOR TREATING HYPERTRIGLYCERIDEMIA
    Publication number: 20180245077
    Abstract: The present invention provides compositions comprising therapeutic nucleic acids such as siRNA that target ApoC3 and ANGPTL3 expression, lipid particles comprising one or more (e.g., a combination) of the therapeutic nucleic acids, and methods of delivering and/or administering the lipid particles (e.g., for treating hypertriglyceridemia in humans).
    Type: Application
    Filed: March 21, 2016
    Publication date: August 30, 2018
    Applicant: PROTIVA BIOTHERAPEUTICS, INC.
    Inventors: Ting CHIU, Narayanan HARIHARAN, Amy C. H. LEE, Christopher Justin PASETKA, Janet Ruth PHELPS, Nicholas Michael SNEAD, Andrew Anthony WIECZOREK
  • COMPOSITIONS AND METHODS FOR SILENCING HEPATITIS B VIRUS GENE EXPRESSION
    Publication number: 20180208932
    Abstract: The present invention provides compositions comprising therapeutic nucleic acids such as siRNA that target Hepatitis B virus (HBV) gene expression, lipid particles comprising one or more (e.g., a combination) of the therapeutic nucleic acids, and methods of delivering and/or administering the lipid particles (e.g., for treating HBV infection and/or HDV infection in humans).
    Type: Application
    Filed: July 28, 2016
    Publication date: July 26, 2018
    Applicant: ARBUTUS BIOPHARMA CORPORATION
    Inventors: Amy C. H. LEE, Nicholas Michael SNEAD, Emily P. THI